| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |